CVS Pulling Popular Cold Meds From Shelves After Report Deems Them to Be Useless
Medically reviewed by Drugs.com.
By Physician’s Briefing Staff HealthDay Reporter
FRIDAY, Oct. 20, 2023 -- CVS Health plans to pull cold medications that contain phenylephrine from its store shelves after federal regulators determined recently that the decongestant does not work.
Oral phenylephrine is an active ingredient in such well-known products as Sudafed and Dayquil. A U.S. Food and Drug Administration advisory committee ruled last month that the ingredient was useless in easing congestion.
"We are removing certain oral cough and cold products that contain phenylephrine as the only active ingredient from CVS Pharmacy stores," the company told CBS MoneyWatch. "Other oral cough and cold products will continue to be offered to meet consumer needs."
Another drugstore chain, Walgreens, said it "follows FDA regulations," but did not say if it would stop selling the medications.
"We are closely monitoring the situation and actively partnering with the Walgreens Office of Clinical Integrity and suppliers on appropriate next steps," a spokesperson told CBS MoneyWatch.
Medications that contain phenylephrine account for $1.8 billion in annual sales, according to FDA data.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
Study Addresses Nasal Rinsing and Nonkeratitis Acanthamoeba Infection
MONDAY, March 18, 2024 -- In a report published in the April issue of Emerging Infectious Diseases, the details of 10 cases of nonkeratitis Acanthamoeba infection are described...
Validated COuGH RefleX Score Can Predict Likelihood of GERD
WEDNESDAY, March 6, 2024 -- The validated Cough, Overweight/Obesity, Globus, Hiatal Hernia, Regurgitation, and Male Sex (COuGH RefluX) score can predict the likelihood of proven...
Phenylephrine Sales Sizeable and Steady Despite Efficacy Concerns
TUESDAY, Feb. 13, 2024 -- Despite concerns about clinical efficacy, phenylephrine was the most common oral decongestant sold in the United States from 2012 to 2021, according to a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.